Approvals/NMPA/Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

Approved

化学药品

Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation

四川普锐特药业有限公司🇨🇳 National Medical Products Administration

Approval Id: 8iDnBnAo9TF
Approval Number: 国药准字H20253521
Generic Name: 沙美特罗替卡松吸入粉雾剂
Generic Name En: Salmeterol Xinafoate and Fluticasone Propionate Powder for Inhalation
Drug Type: 化学药品
Dosage Form: 吸入粉雾剂
Strength: 每泡含昔萘酸沙美特罗50μg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松250μg，递送剂量为昔萘酸沙美特罗47µg（按C₂₅H₃₇NO₄计）与丙酸氟替卡松231µg
Reg Date: 2025-03-04
Company Name: 四川普锐特药业有限公司
Company Address: 四川省成都高新区安泰五路566号
Production Company Name: 四川普锐特药业有限公司
Production Company Address: 成都市高新区安泰五路566号
Company Detail Path: /organization/si-chuan-pu-rui-te-yao-ye-you-xian-gong-si
Production Company Detail Path: /organization/si-chuan-pu-rui-te-yao-ye-you-xian-gong-si

Approved

Agency

NMPA

Country

🇨🇳

Approval Date

Mar 4, 2025

Approval ID

8iDnBnAo9TF

Type

化学药品